Free Trial

Ventas (VTR) Stock Forecast & Price Target

Ventas logo
$58.93 +0.17 (+0.29%)
(As of 05:27 PM ET)

Ventas - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
2
Buy
8

Based on 10 Wall Street analysts who have issued ratings for Ventas in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 10 analysts, 2 have given a hold rating, 7 have given a buy rating, and 1 has given a strong buy rating for VTR.

Consensus Price Target

$65.67
11.43% Upside
According to the 10 analysts' twelve-month price targets for Ventas, the average price target is $65.67. The highest price target for VTR is $75.00, while the lowest price target for VTR is $53.00. The average price target represents a forecasted upside of 11.43% from the current price of $58.93.
Get the Latest News and Ratings for VTR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ventas and its competitors.

Sign Up

VTR Analyst Ratings Over Time

TypeCurrent Forecast
12/24/23 to 12/23/24
1 Month Ago
11/24/23 to 11/23/24
3 Months Ago
9/25/23 to 9/24/24
1 Year Ago
12/24/22 to 12/24/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
8 Buy rating(s)
Hold
2 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$65.67$63.63$58.67$50.62
Forecasted Upside11.43% Upside0.12% Upside-8.29% Downside1.43% Upside
Consensus Rating
Moderate Buy
Buy
Moderate Buy
Moderate Buy

VTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

VTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Ventas Stock vs. The Competition

TypeVentasFinance CompaniesS&P 500
Consensus Rating Score
2.90
2.50
2.51
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside11.43% Upside19.42% Upside14.28% Upside
News Sentiment Rating
Positive News

See Recent VTR News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/20/2024Robert W. Baird
2 of 5 stars
 Boost TargetNeutral ➝ Neutral$65.00 ➝ $66.00+14.33%
12/19/2024Wedbush
4 of 5 stars
 Reiterated RatingOutperform$75.00+29.92%
12/5/2024Mizuho
3 of 5 stars
 Lower TargetOutperform ➝ Outperform$71.00 ➝ $68.00+9.45%
10/11/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector Perform ➝ Sector Perform$59.00 ➝ $65.00+4.67%
10/1/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Feldman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$61.00 ➝ $71.00+10.71%
9/16/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$64.00 ➝ $70.00+8.34%
8/9/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Rosivach
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/9/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$52.00 ➝ $63.00+6.38%
1/30/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$60.00+24.77%
1/16/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$48.00 ➝ $53.00+7.92%
10/11/2023BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$47.00+10.48%
9/22/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$52.00 ➝ $51.00+18.85%
9/20/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeStrong-Buy ➝ Outperform$55.00 ➝ $53.00+21.98%
9/7/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$45.00 ➝ $47.00+10.23%
8/30/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$49.00 ➝ $48.00+10.23%
4/25/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$57.00 ➝ $55.00+20.67%
4/12/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$51.00 ➝ $50.00+12.76%
2/1/2023KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$56.00 ➝ $55.00+6.16%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 07:37 PM ET.


Should I Buy Ventas Stock? VTR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, December 22, 2024. Please send any questions or comments about these Ventas pros and cons to contact@marketbeat.com.

Ventas
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Ventas, Inc.:

  • Recent upgrades from multiple brokerages, including Wells Fargo & Company raising their price target to $71.00, indicate strong confidence in the stock's potential for growth.
  • The current stock price is $59.91, which is below the average target price of $65.63, suggesting that the stock may be undervalued and could offer a buying opportunity.
  • Ventas, Inc. has a solid market capitalization of approximately $25.13 billion, which reflects its stability and ability to weather market fluctuations.
  • The company has received a consensus rating of "Moderate Buy" from analysts, with seven analysts giving buy ratings, which suggests positive sentiment in the market.
  • Ventas, Inc. is focused on the growing aging population, positioning itself well in the healthcare real estate investment trust (REIT) sector, which is expected to see increased demand.

Ventas
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Ventas, Inc. for these reasons:

  • The stock was recently downgraded to a "sell" rating by StockNews.com, indicating potential concerns about its future performance.
  • Ventas, Inc. has a high debt-to-equity ratio of 1.39, which suggests that the company is heavily reliant on debt financing, potentially increasing financial risk.
  • The company has a negative price-to-earnings (P/E) ratio of -352.39, indicating that it is currently not generating profits, which can be a red flag for investors.
  • Insider selling activity, such as the CEO selling over 121,000 shares, may signal a lack of confidence in the company's short-term prospects.
  • The stock has experienced volatility, with a 12-month low of $41.45 and a high of $67.61, which may deter risk-averse investors.

VTR Forecast - Frequently Asked Questions

According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Ventas is $65.67, with a high forecast of $75.00 and a low forecast of $53.00.

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ventas in the last year. There are currently 2 hold ratings, 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" VTR shares.

According to analysts, Ventas's stock has a predicted upside of 11.43% based on their 12-month stock forecasts.

Over the previous 90 days, Ventas's stock had 1 upgrade by analysts.

Ventas has been rated by research analysts at Mizuho, Robert W. Baird, Scotiabank, Wedbush, and Wells Fargo & Company in the past 90 days.

Analysts like Ventas more than other "finance" companies. The consensus rating for Ventas is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how VTR compares to other companies.


This page (NYSE:VTR) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners